Truist Securities adjusted its outlook on Confluent Inc (NASDAQ:CFLT), increasing the price target to $40 from the previous ...
In the fourth quarter of 2024, the US banking industry reported a smaller overall asset base and upgraded its funding profile ...
Truist analyst Joel Fishbein lowered the firm’s price target on Rapid7 (RPD) to $35 from $38 and keeps a Hold rating on the ...
Truist raised the firm’s price target on Palomar (PLMR) to $150 from $112 and keeps a Buy rating on the shares after its Q4 earnings beat. The ...
Truist Financial (NYSE:TFC) stock gained 3.0% in Friday premarket trading after the bank issued strong Q1 2025 guidance and scored a Q4 earnings beat as both net interest income and income from ...
Truist Financial is a leading U.S. commercial ... including share repurchases planned at $500 million for Q4 2024. Management projected cautious optimism for 2025, focusing on maintaining positive ...
Truist analyst David MacDonald raised the firm’s price target on CVS Health (CVS) to $76 from $60 and keeps a Buy rating on ...
Truist analyst Mark Hughes raised the firm’s price target on Frontdoor (FTDR) to $67 from $58 and keeps a Buy rating on the shares. Truist ...
Truist's net income came to $1.2 billion, or 91 cents per share in Q4, a rise from $1.1 billion, or 81 cents per share in the same period a year earlier. The bank's latest Q4 net income beat ...
CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results